Preferred Label : Screening Study;

NCIt synonyms : Screening Trial;

NCIt related terms : SCREENING; screening trials;

NCIt definition : Clinical studies testing the efficacy of devices, techniques, procedures, or tests for the purpose of detecting the presence of disease, usually before there are any symptoms.;

Alternative definition : CDISC-GLOSS: A type of study designed to assess or examine methods of identifying a condition (or risk factors for a condition) in people who are not yet known to have the condition (or risk factor). (Clinicaltrials.gov);

Details


Main resources

You can consult :


http://beh.santepubliquefrance.fr/beh/2024/6-7/2024_6-7_3.html
2024
France
journal article
Substance Screening
Screening Study
french
Organization
Tuberculosis
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Relocation
france
Genetic Screening
Other Agency or Organization
mass screening
organization
Cancer Screening
Trial Screening
CHFR Gene
ukraine
tuberculosis
Site Screening
Replacement
Checkup
screening
tuberculosis, nos
Balance Sheet
Last Screening
tuberculosis
Reposition
Eligibility Determination
Organization Name

---
https://beh.santepubliquefrance.fr/beh/2024/6-7/2024_6-7_3.html
2024
France
journal article
Eligibility Determination
CHFR Gene
screening
Replacement
Relocation
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
ukraine
Other Agency or Organization
Balance Sheet
Screening Study
tuberculosis
organization
tuberculosis, nos
france
Tuberculosis
Checkup
Organization
tuberculosis
Cancer Screening
Site Screening
Trial Screening
Reposition
mass screening
Substance Screening
Last Screening
Genetic Screening
Organization Name
french

---
https://iris.who.int/handle/10665/376140
2024
Switzerland
scientific and technical information
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Diastolic Blood Pressure
Diabetes Mellitus
Cancer Screening
Antigua and Barbuda
Trial Screening
screening
Engaged
Eligibility Determination
screening for diabetes
Substance Screening
Improved
serbia
quality improvement
Enhance
Screening Study
registries
diabetes mellitus
Involvement
prejudice
Twenty Eight
Site Screening
Notification
mass screening
Last Screening
Have Diabetes
Genetic Screening
Propofol Infusion Syndrome
November

---
https://www.cochrane.org/fr/CD001431/COMMUN_les-outils-daide-la-decision-pour-les-patients-confrontes-des-decisions-relatives-un-traitement
2024
United Kingdom
review of literature
french abstract
tool, nos
Substance Screening
Decision Aid
Tool
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Site Screening
Screening Study
has patient
decision support techniques
Last Screening
mass screening
screening
operations research
Medically Treated Reflux
Genetic Screening
decision aids
Patient
Cancer Screening
A^y/a
patients
Eligibility Determination
Trial Screening
Scientific Equipment

---
https://publications.msss.gouv.qc.ca/msss/document-001746/
2024
Canada
patient education handout
deafness
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Eligibility Determination
Scheduled
infant, newborn
screening
Program
Newar Language
Screening Study
NES Gene
Cancer Screening
New Lesion Identification
LGI1 wt Allele
deafness
Substance Screening
neonatal screening
deafness, nos
Trial Screening
Deafness
Site Screening
Genetic Screening
Schedule
newborn, nos
ANGPTL4 wt Allele
Last Screening

---
https://www.canada.ca/fr/sante-publique/services/vih-sida/guide-depistage-diagnostic-infection-vih.html
2024
Canada
guideline
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Substance Screening
HIV Infection
viruses
hiv infections
Cancer Screening
no diagnosis
mass screening
HIV Infection Diagnosis
human immunodeficiency virus infection, nos
HIV
screening
Screening Study
Last Screening
humans
Guide Device
Human Immunodeficiency Virus
Eligibility Determination
human immunodeficiency virus, nos
Handbook
Genetic Screening
Date of Diagnosis
Diagnosis Study
Trial Screening
Site Screening
Diagnosis Code

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-du-diabete-de-type-2-et-evaluation-du-risque-cardiovasculaire.html
2024
Canada
technical report
Cardiovascular Risk
Last Screening
Eligibility Determination
Genetic Screening
Trial Screening
Health Risk Assessment
Murine Cardiovascular System
Type 2 Diabetes Mellitus
Site Screening
Cancer Screening
mass screening
diabetes non-insulin dependent
screening for diabetes
screening
risk assessment
diabetes mellitus, type 2
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Screening Study
Cardiovascular
Cardiovascular System
cardiovascular risk
Substance Screening

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1367
2024
France
public health guidelines
mass screening
Trial Screening
Pregnancy
Eligibility Determination
pregnancy
Last Screening
pregnancy complications, infectious
Substance Screening
cytomegalovirus infections
Cytomegaloviral Infection
Cancer Screening
Genetic Screening
Screening Study
Site Screening
cytomegalovirus infection, nos
pregnancy, nos
Pregnant
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening

---
https://www.cmg.fr/wp-content/uploads/2024/02/Le-depistage-cutane-CMG2024.pdf
2024
France
patient education handout
Substance Screening
Trial Screening
Cancer Screening
skin, nos
Screening Study
Site Screening
Last Screening
mass screening
screening
Cutaneous
Genetic Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Eligibility Determination
Cutaneous Route of Administration

---
https://dumas.ccsd.cnrs.fr/dumas-04245064
2023
France
dissertations, academic
Going Well
general practitioners
Eligibility Determination
Last Screening
Screening Study
Trial Screening
Liver Specific Alkaline Phosphatase Measurement
Prevention
Charge
Autoimmune Lymphoproliferative Syndrome
Prevention Study
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
mass screening
Autonomic Nervous System
Cyberbullying
Genetic Screening
Cancer Screening
screening
patient care management
Substance Screening
Clinical Trial Registry Identifier
Preventive Intervention
Site Screening

---
https://pepite-depot.univ-lille.fr/RESTREINT/Th_Medecine/2023/2023ULILM126.pdf
2023
France
dissertations, academic
Screening Study
qualitative research
General Qualifier
screening
general practitioners
mass screening
violence
Violence

---
http://thesesante.ups-tlse.fr/4447/
2023
France
dissertations, academic
Agreement Score 4
Cancer Screening
Trial Screening
Illness Intrusiveness Rating 4
Autonomic Nervous System
general practice
Current Reformed Smoker Within Past 15 Years
Thought Score 4
Upset Score 4
Substance Screening
Child Relation
Clinical Status Ordinal Scale Outcome 4
Afghanistan
Site Screening
Intensity and Distress 4
child, nos
Genetic Screening
screening
Gleason Grade Group 4
Severity of Symptom Score 4
pediatrics
Physical Examination
child
mass screening
Child Individual
Screening Study
Primary Care Provider
Four
Eligibility Determination
Symptoms Extent Score 4
ECOG Performance Status 4
Last Screening
general practitioners
Phase IV Trial
Fear Score 4
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening

---
https://www.paediatrieschweiz.ch/fr/depistage-de-la-dysplasie-developpementale-de-la-hanche-en-suisse/
2023
Switzerland
journal article
Swiss Mice (sdc)
RPL29 wt Allele
Oral Health Impact Profile
Developmental Dysplasia of the Hip
Cancer Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Genetic Screening
Trial Screening
Ischium
dysplasia, nos
Hip Joint
screening
swiss
2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine
GJB2 wt Allele
Zinc Finger FYVE Domain-Containing Protein 9
SDHB wt Allele
E3 Ubiquitin-Protein Ligase RNF31
Screening Study
ZFYVE9 wt Allele
Last Screening
Hsc70-Interacting Protein
ST13 wt Allele
Eligibility Determination
Swiss
Hedgehog-Interacting Protein
REG3A wt Allele
60S Ribosomal Protein L29
Hypoxic Ischemic Encephalopathy
switzerland
Site Screening
Substance Screening
Dysplasia
HHIP wt Allele
Urticaria
Hip
Health Information Exchange
RNF31 wt Allele
mass screening

---
https://www.enfant-encyclopedie.com/anxiete-et-depression/selon-experts/depistage-et-evaluation-de-lanxiete-et-de-la-depression-pendant
2023
Canada
scientific and technical information
Assessment
Worry
Anxiety
Evaluation
Site Screening
Last Screening
anxiety disorder of childhood, nos
depression
depression, nos
Substance Screening
Feel Anxious
Eligibility Determination
Anxiety Disorder
depressive disorder
Screening Study
evaluation studies as topic
screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
anxiety
mass screening
Early Childhood
Anxiety, CTCAE 3.0
Physical Examination
Trial Screening
Cancer Screening
Childhood Depression
Genetic Screening
Assessment

---
https://n2t.net/ark:/47881/m600023w
2023
France
dissertations, academic
Family Practice
Cancer Screening
Development Batch
tool, nos
Maturation
patient care management
general practice
Biomedicine
mass screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Substance Screening
Last Screening
Charge
Genetic Screening
screening
Development Lot
Screening Study
Eligibility Determination
teaching
Trial Screening
Tool
Scientific Equipment
Site Screening
Psychological Trauma
pedagogy

---
https://nuxeo.u-bourgogne.fr/nuxeo/site/esupversions/838246d1-13f5-45db-9ec7-f7c7599fd7c9
2023
France
dissertations, academic
Last Screening
Site Screening
Cancer Screening
Going Well
Violence
Biomedicine
screening
Genetic Screening
Eligibility Determination
general practice
Family Practice
County
Substance Screening
Trial Screening
mass screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Screening Study
Burgundy Flavor
state medicine
spouse abuse

---
https://dumas.ccsd.cnrs.fr/dumas-04413875
2023
France
dissertations, academic
depression, postpartum
Binding
Woman
tool use behavior
female
perinatal state, nos
child
reactive attachment disorder
Fastener Device
Site Screening
Fix
women
Female Phenotype
Last Screening
Childhood Depression
mother, nos
Scientific Equipment
depressive disorder
mass screening
Wife
child, nos
Cancer Screening
depression
Substance Screening
Use
Perinatal Depression
Tool
Screening Study
Genetic Screening
Trial Screening
psychometrics
Phenylmercuric Acetate
Oman
screening
tool, nos
Eligibility Determination
depression, nos
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening

---
https://dumas.ccsd.cnrs.fr/dumas-04239347
2023
France
dissertations, academic
rheumatic diseases
Rheumatism
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Screening Study
Review
comorbidity
Site Screening
GDC Comorbidity Terminology
Patient
Genetic Screening
Eligibility Determination
Last Screening
physicians
Substance Screening
mass screening
Cancer Screening
patients
Medication
rheumatism, nos
Inflammatory
Systematic Review
Implementation
has patient
Trial Screening
rheumatic fever

---
https://dumas.ccsd.cnrs.fr/dumas-04208921
2023
France
dissertations, academic
Violence
violence
primary health care
Scientific Equipment
Country Code
Last Screening
File Validated
Woman
Tool
Netherlands
Eligibility Determination
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
women
nursing
principal
Substance Screening
Tumor Identifier Evaluator Identifier
Cancer Screening
Going Well
screening
Primary Care
Validation
primary health care
Organisation for Economic Co-Operation and Development
Validation Batch
tool, nos
Trial Screening
Screening Study
Genetic Screening
CDISC SEND Country Terminology
mass screening
Site Screening

---
https://www.srlf.org/article/thromboses-veineuses-liees-aux-catheters-patients-soins-intensifs-reanimation-interet-du
2023
France
critical appraisal or critical reading
Venous Thrombosis
Eligibility Determination
Last Screening
Resuscitation
critical care
Catheterization
Cancer Screening
has patient
Screening Study
What Month is it
catheterization of vein, nos
Reasoning
Substance Screening
patient care
Trial Screening
venous thrombosis
Intensive Care Stay Required
screening
intensive care
Genetic Screening
mass screening
Patient Care
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
venous thrombosis, nos
catheters
Site Screening

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1348
2023
France
scientific and technical information
screening
Biological
syphilis
biology
Blood
Screening Study
blood donor, nos
Biological or Textual Reference to Actual Test or Parameter
biology
Genetic Screening
Murine Blood
Eligibility Determination
Cancer Screening
Trial Screening
Syphilis
blood donors
mass screening
Site Screening
Blood Sample
Biological Son
Biological Agent
Substance Screening
syphilis, nos
Last Screening
Biological Challenge Agent
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Biology

---
https://www.cmg.fr/wp-content/uploads/2023/03/CMG-Prevention-et-depistage-en-medecine-generale.pdf
2023
France
scientific and technical information
health personnel
Genetic Screening
preventive medicine
Splayed
Preventive Medicine
Substance Screening
Trial Screening
Last Screening
Eligibility Determination
screening
Primary Care Provider
mass screening
Cancer Screening
Site Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Screening Study
general practice
general practitioners

---
https://www.sf2h.net/k-stock/data/uploads/2023/01/Avis-SFM-Depistage-des-MO-en-NN-2023.pdf
2023
France
guideline
organ part
Trial Screening
Cancer Screening
Eligibility Determination
Neither Agree or Disagree
Genetic Screening
Organism
mass screening
neonatology
judgment
Patient
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
Million Organisms
Site Screening
Best Practice
Organisms Category
neonatologist
Last Screening
screening
Micro
organizations
Microscopic
Stage 0 Squamous Cell Carcinoma
best practices
has patient
patients
Relative Value
microscopy
Screening Study
Substance Screening

---
https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2023-49/issue-9-september-2023/ccdrv49i09a04af-fra.pdf
2023
Canada
scientific and technical information
Genetic Screening
Last Screening
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
gonorrhea
pregnancy
Substance Screening
chlamydia, nos
Pregnancy
gonorrhea, nos
Cancer Screening
Site Screening
health planning guidelines
Gonorrhea
chlamydia
Working Kelpie
Screening Study
Eligibility Determination
screening
canada
Chlamydia
pregnancy, nos
Chlamydial Infection
Chlamydia Measurement
Trial Screening
mass screening
Pregnant

---
https://ged.univ-rennes1.fr/nuxeo/site/esupversions/e411ab5a-5329-4d5d-84af-cff45caad3b2
2023
France
dissertations, academic
Centi
measures
central
Hub Device
screening
Preventive Intervention
Prevention
COVID-19 Infection
mass screening
COVID-19
weights and measures
qualitative research
Prevention Study
Screening Study
Center

---
https://dumas.ccsd.cnrs.fr/dumas-03999150
2023
France
dissertations, academic
Twelve
Algeria
Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain
screening
Lowest
Low Calcium Level
Medication
Screening for Skin Cancer
Lower
Value Below Reference Range
medicine
IPSS Risk Category Low
Low LDH Level
Serum CEA Level Low
Screening Study
Bottom
Low Mitosis-Karyorrhexis Index
GDC Biospecimen Anatomic Site Terminology
mass screening
general practitioners
Malignant Germ Cell International Collaborative Risk Classification, Low
Serum CA 19-9 Low
skin, nos
IPSS-R Risk Category Low
Low Level
qualitative research

---
https://dumas.ccsd.cnrs.fr/dumas-04171805
2023
France
dissertations, academic
Tool
evaluation studies as topic
Substance Screening
Assessment
Biomedicine
general practice
hypertension
pediatrics
Screening Study
Pediatricians
Hypertension
screening
Trial Screening
Cancer Screening
Scientific Equipment
tool, nos
Human Cells, Tissues, and Cellular and Tissue-Based Products Screening
pediatrician
Physical Examination
Site Screening
Assessment
hypertensive disease, nos
Eligibility Determination
Family Practice
Evaluation
Pediatrics
Genetic Screening
mass screening
Last Screening

---
Nous contacter.
04/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.